Schain Research
Philip Abrahamsson has a diverse background in investment and board governance, currently serving as an Investment Director at Stella Capital and a Styrelseledamot at Nion since October 2024. With board member roles at various companies including Nordicstation, One Agency Sweden AB, Polar Cape, Qvalia, Ciencia Technology, and Schain Research, as well as involvement with By Malina and Soft Goat, Philip demonstrates extensive expertise in strategic decision-making and investment management. Philip's academic credentials include a Civilekonom degree in Business Administration and Finance from Jönköping International Business School, alongside studies at City University of Hong Kong and a Bachelor's degree in Commercial and Tax Law from Jönköping University.
This person is not in the org chart
This person is not in any teams
Schain Research
Schain Research is a research consultancy company specialized in health data sciences and real world evidence to support pharmaceutical companies throughout all phases of drug development. We advance knowledge and contribute to accelerated drug development processes, evidence based healthcare and improved patient outcomes by applying advanced analytics on population-based data sources. Our team has extensive experience from R&D, medical affairs, market access, biostatistics, epidemiology and economics.